NACDS RAB Market Immersion in Chicago charts vision for futureDiscussions centered on artificial intelligence, organized retail crime, reimbursement reform, real estate trends, retail media networks, innovation in retail and the state of wellness. FDA approves Dong-A ST’s Stelara biosimilarImuldosa is used for the treatment of patients with autoimmune diseases such as plaque psoriasis, psoriatic arthritis, Crohn’s disease and ulcerative colitis. Biden administration releases preliminary list of $2 generic drugs for Medicare recipients Participation in the model would be voluntary for Part D sponsors and, pending further development, could start as early as January 2027. Teva’s Prolia biosimilar candidate accepted for review by FDA, EU EMA Prolia is indicated to treat certain conditions that lead to high risk for fracture, including osteoporosis in postmenopausal women. Glenmark pays $25M to resolve alleged False Claims Act liability for drug price-fixing The government alleged that between 2013 and 2015, Glenmark paid and received compensation prohibited by the Anti-Kickback Statute. Rite Aid kicks off Tackle the Flu sweepstakes during football season Customers in select cities can enter for a chance to win two tickets to see their local professional football team. Sanofi in discussions to sell a controlling stake in Opella Opella is the world's third-largest company in the OTC and vitamins, minerals and supplements market. CVS Health discontinuing certain infusion services CVS Health is planning to close or sell 29 regional pharmacies in the coming months. URAC releases specialty pharmacy report Over the five-year period, URAC-accredited pharmacies responded to patient calls within 30 seconds 75% of the time, improving to 86% by 2023. Camber touts 8 generic product launches in Q3-2024 The company launched several other generics during Q1 and Q2. 1 2 3 4 5 Next Last